Filter
191
Text search:
toxicology
Featured
Recommendations
18
New Publications
35
Language
Document type
No document type
109
Studies & Reports
33
Guidelines
32
Manuals
7
Strategic & Response Plan
4
Fact sheets
3
Situation Updates
2
Training Material
1
Countries / Regions
India
10
Western and Central Europe
10
Kenya
8
Africa
6
Syria
5
USA
4
Global
4
Tanzania
3
Rwanda
3
Namibia
3
Liberia
2
Uganda
2
Zimbabwe
2
Zambia
2
North Macedonia
2
Latin America and the Carribbean
2
Eastern Europe
2
Albania
2
Sierra Leone
1
Nigeria
1
Ethiopia
1
Philippines
1
Iraq
1
Indonesia
1
Bangladesh
1
Sudan
1
Serbia
1
Ukraine
1
Botswana
1
Lesotho
1
Eastern Europe and Central Asia
1
Asia
1
Southern Africa
1
Moldova
1
Authors & Publishers
Publication Years
Category
Countries
44
Public Health
12
Clinical Guidelines
12
Key Resources
10
Women & Child Health
4
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
Mental Health
40
Specific Hazards
17
Planetary Health
15
COVID-19
13
Pharmacy
13
Rapid Response
9
Conflict
7
TB
7
AMR
6
NTDs
6
Ebola
5
HIV
4
Refugee
3
Zika
3
Disability
2
Natural Hazards
2
Global Health Education
2
NCDs
2
Caregiver
1
Improvements in water sanitation and hygiene (WASH) and wastewater management in all sectors are critical elements of preventing infections and reducing the spread of antimicrobial resistance (AMR) as identified in the Global Action Plan to combat AMR. Yet, at present, WASH and wastewater management
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
This manual describes methods for investigating clusters or outbreaks that may be of chemical origin and describes the importance of a structured, coordinated, collaborative multidisciplinary, multi-agency approach at local, regional, national and international levels.
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication studies and on WHO risk communication guidelines.
This document is a practical guide to the management of burn injuries for healthcare professionals everyhwere who are non-burn specialistsi
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health risks in their given health risk assessment contexts
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati
...
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
A Snapshot of European Collection Schemes
